Uricift-D Tablet MR
By Uricift-D
Rx
10 Tablet MR in a Strip

Composition
Tamsulosin(0.4mg) + Dutasteride(0.5mg)

Manufacturer - Biophar Lifesciences Pvt Ltd
Elante Office,Industrial&Buisness Park, Phase-I,Chandigarh(UT)-160002, Registered Office : #34,Raipur Kalan, Chandigarh - 160102

Expires on or after
April, 2027

liver
When it comes to using Uricift-D Tablet MR, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Uricift-D Tablet MR, so consulting with your doctor is crucial. However, it is advised not to use Uricift-D Tablet MR in patients with severe liver disease. Always seek guidance from your healthcare provider regarding the use of this medication if you have any liver concerns.

kidney
Limited information is available on the use of Uricift-D Tablet MR in patients with kidney disease. Consult your doctor before use.

alcohol
When taking Uricift-D Tablet MR, be cautious as it can intensify drowsiness when consumed with alcohol.

driving
Caution Uricift-D Tablet MR may cause drowsiness, affect vision, or reduce alertness. Avoid driving if experiencing these effects.

pregnancy
It is better to consult your doctor before using Uricift-D Tablet MR during pregnancy as specific information on its safety during pregnancy is not available.

breastfeeding
It is better to consult your doctor before using Uricift-D Tablet MR during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | UROLOGY |
Action Class | - |
₹88
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024